A detailed history of Summer Road LLC transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Summer Road LLC holds 14,885,633 shares of OCUL stock, worth $131 Million. This represents 98.56% of its overall portfolio holdings.

Number of Shares
14,885,633
Previous 14,360,633 3.66%
Holding current value
$131 Million
Previous $131 Million 22.09%
% of portfolio
98.56%
Previous 100.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$4.2 - $8.69 $2.21 Million - $4.56 Million
525,000 Added 3.66%
14,885,633 $102 Million
Q1 2024

May 15, 2024

BUY
$3.85 - $10.93 $25.8 Million - $73.2 Million
6,700,083 Added 87.46%
14,360,633 $131 Million
Q4 2023

Feb 14, 2024

BUY
$2.08 - $4.52 $3.2 Million - $6.95 Million
1,538,461 Added 25.13%
7,660,550 $34.2 Million
Q4 2022

Feb 14, 2023

BUY
$2.61 - $4.41 $71,326 - $120,516
27,328 Added 0.45%
6,122,089 $17.2 Million
Q3 2022

Nov 14, 2022

BUY
$4.09 - $6.5 $613,500 - $975,000
150,000 Added 2.52%
6,094,761 $25.3 Million
Q1 2022

May 13, 2022

BUY
$4.83 - $7.35 $869,400 - $1.32 Million
180,000 Added 3.12%
5,944,761 $29.4 Million
Q4 2021

Feb 14, 2022

BUY
$6.16 - $12.07 $898,744 - $1.76 Million
145,900 Added 2.6%
5,764,761 $40.2 Million
Q4 2020

Feb 16, 2021

BUY
$7.91 - $22.95 $3,456 - $10,029
437 Added 0.01%
5,618,861 $116 Million
Q2 2020

Aug 14, 2020

BUY
$4.67 - $8.95 $1.7 Million - $3.25 Million
363,636 Added 6.92%
5,618,424 $46.8 Million
Q1 2020

May 14, 2020

BUY
$3.95 - $7.4 $5.73 Million - $10.7 Million
1,450,000 Added 38.11%
5,254,788 $26 Million
Q1 2019

May 15, 2019

BUY
$3.51 - $4.77 $69,982 - $95,104
19,938 Added 0.53%
3,804,788 $15.1 Million
Q4 2018

Feb 14, 2019

BUY
$3.87 - $7.11 $2.93 Million - $5.38 Million
757,362 Added 25.02%
3,784,850 $15.1 Million
Q1 2018

May 08, 2018

BUY
$4.66 - $7.08 $14.1 Million - $21.4 Million
3,027,488 New
3,027,488 $19.7 Million

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $676M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Summer Road LLC Portfolio

Follow Summer Road LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summer Road LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summer Road LLC with notifications on news.